Cracking the Code to Post Trial Access
Early Access Care will be participating at the Operationalize Expanded Access Programs on March 19 - 21, 2024 in Boston, MA. Join colleagues across the pharmaceutical industry as they come together to share ideas and learn about Expanded Access, Compassionate Use, and Post Trial Access programs.
As an Expertise partner of the program, Early Access Care will present information on key distinctions between a Post Trial Access program and an extension study along with key considerations for program design and implementation with a focus upon regulatory considerations for post-trial access. Opportunities for data collection will also be discussed.
Anne Cropp will be joined by Christine Syltevik, Senior Director, Clinical Operations, Prilenia Therapeutics as they share their experiences learnings in planning and implementing a Post-Trial Access Program.
Early Access Care is a full-scale specialist service provider of Compassionate Use and Named Patient Programs, ranging from programme planning, protocol development, end-to-end operational management, Real World Data services, and a variety of customized service offerings. We work with biotech and pharmaceutical companies to set up and manage programs in the pre- and post-approval space, including post-trial access, managing all regulatory and logistical aspects of early access. Speak with one of our representatives at the EAC booth to find out more about how our service and staff may support your plans.